{"id":"https://openalex.org/W1997109879","doi":"https://doi.org/10.1016/j.jalz.2012.05.533","title":"P1\u2010252: Gamma\u2010secretase modulators demonstrate similar exposure\u2010response relationship in the rat and guinea pig","display_name":"P1\u2010252: Gamma\u2010secretase modulators demonstrate similar exposure\u2010response relationship in the rat and guinea pig","alternate_titles":[],"publication_year":2012,"publication_date":"2012-07-01","ids":{"openalex":"https://openalex.org/W1997109879","doi":"https://doi.org/10.1016/j.jalz.2012.05.533","mag":"1997109879"},"language":"en","primary_location":{"id":"doi:10.1016/j.jalz.2012.05.533","doi":"https://doi.org/10.1016/j.jalz.2012.05.533","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.jalz.2012.05.533","pdf_url":null,"source":{"id":"https://openalex.org/S108427512","display_name":"Alzheimer s & Dementia","issn_l":"1552-5260","issn":["1552-5260","1552-5279"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-3","ki-jl-3","medline","norway-1","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Alzheimer's &amp; Dementia","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1997109879"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5112110150","display_name":"Yasong Lu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Yasong Lu","raw_affiliation_strings":["Pfizer Inc. Groton Connecticut United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer Inc. Groton Connecticut United States","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017377118","display_name":"Kathleen M. Wood","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Kathleen Wood","raw_affiliation_strings":["Pfizer Inc. Groton Connecticut United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer Inc. Groton Connecticut United States","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070099912","display_name":"Stefanus J. Steyn","orcid":"https://orcid.org/0000-0002-0061-5350","observed_orcids":["https://orcid.org/0000-0002-0061-5350"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Stefanus Steyn","raw_affiliation_strings":["Pfizer Inc. Groton Connecticut United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer Inc. Groton Connecticut United States","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103569272","display_name":"Stacey L. Becker","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Stacey Becker","raw_affiliation_strings":["Pfizer Inc. Groton Connecticut United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer Inc. Groton Connecticut United States","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113213832","display_name":"Sarah M. Osgood","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Sarah Osgood","raw_affiliation_strings":["Pfizer Inc. Groton Connecticut United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer Inc. Groton Connecticut United States","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030246630","display_name":"Emily L. Miller","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Emily Miller","raw_affiliation_strings":["Pfizer Inc. Groton Connecticut United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer Inc. Groton Connecticut United States","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Karin Wallace","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Karin Wallace","raw_affiliation_strings":["Pfizer Inc. Groton Connecticut United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer Inc. Groton Connecticut United States","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014893245","display_name":"Emily K. Sylvain","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Emily Sylvain","raw_affiliation_strings":["Pfizer Inc. Groton Connecticut United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer Inc. Groton Connecticut United States","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Michael Marconi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Michael Marconi","raw_affiliation_strings":["Pfizer Inc. Groton Connecticut United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer Inc. Groton Connecticut United States","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Doug Johnson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Doug Johnson","raw_affiliation_strings":["Pfizer Inc. Groton Connecticut United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer Inc. Groton Connecticut United States","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057729742","display_name":"Martin Pettersson","orcid":"https://orcid.org/0000-0001-8748-9539","observed_orcids":["https://orcid.org/0000-0001-8748-9539"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Martin Pettersson","raw_affiliation_strings":["Pfizer Inc. Groton Connecticut United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer Inc. Groton Connecticut United States","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090904031","display_name":"Patrick R. Verhoest","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Patrick Verhoest","raw_affiliation_strings":["Pfizer Inc. Groton Connecticut United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer Inc. Groton Connecticut United States","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060566337","display_name":"Jennifer L. Liras","orcid":"https://orcid.org/0000-0001-5041-1287","observed_orcids":["https://orcid.org/0000-0001-5041-1287"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jennifer Liras","raw_affiliation_strings":["Pfizer Inc. Groton Connecticut United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer Inc. Groton Connecticut United States","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5003879034","display_name":"Kelly R. Bales","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Kelly Bales","raw_affiliation_strings":["Pfizer Inc. Groton Connecticut United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer Inc. Groton Connecticut United States","institution_ids":["https://openalex.org/I180857899"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I180857899"],"apc_list":{"value":4200,"currency":"USD","value_usd":4200},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"8","issue":"4S_Part_5","first_page":null,"last_page":null},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12023","display_name":"Cholinesterase and Neurodegenerative Diseases","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10009","display_name":"Dementia and Cognitive Impairment Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/gamma-secretase-modulators","display_name":"\u03b3-secretase modulators","score":0.9980000257492065},{"id":"https://openalex.org/keywords/amyloid-beta-1-42","display_name":"amyloid-beta 42","score":0.7950000166893005}],"concepts":[{"id":"https://openalex.org/C2778815084","wikidata":"https://www.wikidata.org/wiki/Q79803","display_name":"Guinea pig","level":2,"score":0.8351324796676636},{"id":"https://openalex.org/C111113717","wikidata":"https://www.wikidata.org/wiki/Q725307","display_name":"Pharmacodynamics","level":3,"score":0.6759047508239746},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5888320803642273},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.4873009920120239},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4814295470714569},{"id":"https://openalex.org/C12554922","wikidata":"https://www.wikidata.org/wiki/Q7100","display_name":"Biophysics","level":1,"score":0.37682780623435974},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.30471208691596985},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.27193957567214966},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.27073097229003906}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/j.jalz.2012.05.533","doi":"https://doi.org/10.1016/j.jalz.2012.05.533","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.jalz.2012.05.533","pdf_url":null,"source":{"id":"https://openalex.org/S108427512","display_name":"Alzheimer s & Dementia","issn_l":"1552-5260","issn":["1552-5260","1552-5279"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-3","ki-jl-3","medline","norway-1","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Alzheimer's &amp; Dementia","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2010467057","https://openalex.org/W2014030730","https://openalex.org/W2070457321","https://openalex.org/W2130275226","https://openalex.org/W16834203","https://openalex.org/W2961174618","https://openalex.org/W2426571582","https://openalex.org/W2066663927","https://openalex.org/W1490235836","https://openalex.org/W2088553238"],"abstract_inverted_index":{"Compounds":[0],"that":[1,36,154],"modulate":[2],"g":[3],"-secretase":[4],"(GSMs)":[5],"activity":[6],"to":[7,51,77,148],"selectively":[8],"lower":[9],"brain":[10,112,179],"A\u03b242":[11,169,195],"have":[12],"been":[13],"pursued":[14],"as":[15,142,144,211],"potential":[16],"therapies":[17],"for":[18,97,139,194,215,229],"individuals":[19],"with":[20,123],"Alzheimer's":[21],"disease.":[22],"The":[23,131],"A\u03b2":[24,103,162],"sequence":[25],"in":[26,37,70,105,113,170,174,180],"humans":[27],"and":[28,65,89,102,111,116,129,165,178,183],"guinea":[29,48,90,117,184],"pigs":[30],"is":[31,58,68,75],"identical":[32],"but":[33],"differs":[34],"from":[35,159],"rat.":[38,72],"To":[39],"probe":[40],"the":[41,47,59,71,80,87,106,114,140,175,181,190,209,221],"pharmacodynamic":[42],"(PD)":[43],"effects":[44],"of":[45,83,99,146,157,218,232],"GSMs,":[46,127],"pig":[49],"seems":[50],"be":[52,227],"a":[53,134,171,212],"reasonable":[54],"model;":[55],"however,":[56],"rat":[57,88,115,182,210],"preferred":[60],"species":[61,120],"since":[62],"pharmacokinetic":[63],"(PK)":[64],"safety":[66],"characterization":[67],"conducted":[69],"Therefore,":[73],"it":[74],"critical":[76],"understand":[78],"whether":[79],"exposure-response":[81],"relationship":[82,153,193],"GSMs":[84],"vary":[85],"between":[86,199],"pig.":[91,118,185],"We":[92],"completed":[93],"comprehensive":[94],"time-course":[95],"studies":[96],"measurement":[98],"compound":[100],"concentrations":[101],"levels":[104],"plasma,":[107,176],"cerebrospinal":[108],"fluid":[109],"(CSF),":[110],"Each":[119],"was":[121,155,197],"administered":[122],"two":[124,201],"structurally":[125],"distinct":[126],"GSM67":[128,164],"GSM09.":[130],"data":[132],"enabled":[133],"PK/PD":[135,152,192,205,233],"model,":[136],"which":[137],"accounts":[138],"synthesis":[141],"well":[143],"clearance":[145],"A\u03b2,":[147],"derive":[149],"an":[150],"intrinsic":[151,191],"devoid":[156],"confounds":[158],"PK":[160],"or":[161],"turnover.":[163],"GSM09":[166],"significantly":[167],"reduced":[168],"dose-dependent":[172],"fashion":[173],"CSF,":[177],"For":[186],"all":[187],"three":[188],"compartments,":[189],"lowering":[196],"similar":[198],"these":[200],"species.":[202,236],"Our":[203],"quantitative":[204,222],"analysis":[206],"support":[207],"utilizing":[208],"suitable":[213],"model":[214],"preclinical":[216],"profiling":[217],"GSMs.":[219],"Moreover,":[220],"approach":[223],"described":[224],"here":[225],"can":[226],"used":[228],"further":[230],"assessment":[231],"translatability":[234],"across":[235]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1997109879","counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}
